Related Experiment Videos
Diffuse large B cell lymphoma in a patient with hypocomplementemic urticarial vasculitis.
1Department of Internal Medicine, Hospital de Zafra, Zafra (Badajoz), Spain. jmcromero@eresmas.com
Journal of Postgraduate Medicine
|November 5, 2003
Summary
Hypocomplementemic urticarial vasculitis (HUV) is linked to cancers. This report details a rare case of HUV preceding diffuse large B cell lymphoma, a type of non-Hodgkin lymphoma, by ten years.
Area of Science:
- Immunodermatology
- Oncology
- Hematology
Background:
- Hypocomplementemic urticarial vasculitis (HUV) is an autoimmune condition characterized by urticarial lesions, low complement levels, and vasculitis.
- HUV is recognized to have potential associations with various hematologic malignancies, particularly lymphomas.
- While urticarial vasculitis is linked to lymphomas, the specific association between HUV and non-Hodgkin lymphoma remains under-documented in medical literature.
Observation:
- This case report describes a patient initially diagnosed with Hypocomplementemic urticarial vasculitis (HUV).
- The patient subsequently developed a distinct hematologic malignancy ten years after the initial HUV diagnosis.
- The diagnosed malignancy was identified as diffuse large B cell lymphoma, a subtype of non-Hodgkin lymphoma.
Findings:
- The study presents a unique temporal association between Hypocomplementemic urticarial vasculitis and the subsequent development of diffuse large B cell lymphoma.
- This case highlights a potential, previously undescribed link between HUV and non-Hodgkin lymphoma.
- The ten-year interval between HUV onset and lymphoma diagnosis suggests a possible long-term association.
Implications:
- This case underscores the importance of considering underlying malignancies in patients diagnosed with Hypocomplementemic urticarial vasculitis.
- Further research is warranted to elucidate the potential pathogenetic mechanisms linking HUV and non-Hodgkin lymphoma.
- Clinicians should maintain a high index of suspicion for hematologic neoplasms in patients with persistent or recurrent HUV.